Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Role of LFA-1 and ICAM-1 in Cancer.

Reina M, Espel E.

Cancers (Basel). 2017 Nov 3;9(11). pii: E153. doi: 10.3390/cancers9110153. Review.

2.

ATM meets ERK5.

Angulo-Ibáñez M, Rovira-Clavé X, Espel E.

Aging (Albany NY). 2017 Feb 27;9(2):299-300. doi: 10.18632/aging.101189. No abstract available.

3.

Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.

Granados-Jaén A, Angulo-Ibáñez M, Rovira-Clavé X, Gamez CP, Soriano FX, Reina M, Espel E.

Oncotarget. 2016 Nov 15;7(46):74435-74447. doi: 10.18632/oncotarget.12908.

4.

Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Angulo-Ibáñez M, Rovira-Clavé X, Granados-Jaén A, Downs B, Kim YC, Wang SM, Reina M, Espel E.

Cell Cycle. 2015;14(24):3864-76. doi: 10.1080/15384101.2015.1120914.

5.

Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface.

Rovira-Clavé X, Angulo-Ibáñez M, Tournier C, Reina M, Espel E.

J Leukoc Biol. 2016 Jan;99(1):143-52. doi: 10.1189/jlb.2A0115-034R. Epub 2015 Aug 24.

PMID:
26302753
6.

The PDZ-binding domain of syndecan-2 inhibits LFA-1 high-affinity conformation.

Rovira-Clavé X, Angulo-Ibáñez M, Reina M, Espel E.

Cell Signal. 2014 Jul;26(7):1489-99. doi: 10.1016/j.cellsig.2014.03.012. Epub 2014 Mar 21.

PMID:
24662262
7.

Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface.

Rovira-Clavé X, Angulo-Ibáñez M, Noguer O, Espel E, Reina M.

Immunology. 2012 Nov;137(3):214-25. doi: 10.1111/j.1365-2567.2012.03626.x.

8.

Characterization of ocular surface epithelial and progenitor cell markers in human adipose stromal cells derived from lipoaspirates.

Martínez-Conesa EM, Espel E, Reina M, Casaroli-Marano RP.

Invest Ophthalmol Vis Sci. 2012 Jan 31;53(1):513-20. doi: 10.1167/iovs.11-7550.

9.

Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation.

Teixé T, Nieto-Blanco P, Vilella R, Engel P, Reina M, Espel E.

Mol Immunol. 2008 May;45(10):2905-19. doi: 10.1016/j.molimm.2008.01.033. Epub 2008 Mar 14. Erratum in: Mol Immunol. 2012 Jul;51(3-4):368.

PMID:
18342939
10.

Use of Western blotting filtration to detect UV-cross-linked protein: RNA complexes.

Espel E, Teixé T, Reina M, Vilaró S, Parra JL, Buxadé M.

Anal Biochem. 2006 Jun 1;353(1):138-40. Epub 2005 Dec 6. No abstract available.

PMID:
16620744
11.

The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1.

Buxadé M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, Bain J, Espel E, Proud CG.

Immunity. 2005 Aug;23(2):177-89.

12.

A polymorphism in the 3' untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression.

Puga I, Lainez B, Fernández-Real JM, Buxadé M, Broch M, Vendrell J, Espel E.

Endocrinology. 2005 May;146(5):2210-20. Epub 2005 Jan 27.

PMID:
15677760
13.

The role of the AU-rich elements of mRNAs in controlling translation.

Espel E.

Semin Cell Dev Biol. 2005 Feb;16(1):59-67. Epub 2004 Dec 21. Review.

PMID:
15659340
14.

Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected].

Colomar M, Puga I, López M, Massot M, Jorquera JI, Reina M, Vilaró S, Espel E.

Clin Diagn Lab Immunol. 2003 Sep;10(5):751-6. Erratum in: Clin Diagn Lab Immunol. 2003 Nov;10(6):1161.

15.

Supplemental Content

Loading ...
Support Center